The clinical influence of preformed nonspecific anti-HLA antibodies on single-unit umbilical cord blood transplantation in patients with haematological malignancies

Yue Wu; Baolin Tang; Kaidi Song; Guangyu Sun; Meijuan Tu; Xiang Wan; Wen Yao; Ping Qiang; Tianzhong Pan; Peng Ding; Xiaoyu Zhu

doi:10.1111/bjh.18316

The clinical influence of preformed nonspecific anti-HLA antibodies on single-unit umbilical cord blood transplantation in patients with haematological malignancies

Br J Haematol. 2022 Aug;198(4):e63-e66. doi: 10.1111/bjh.18316. Epub 2022 Jun 17.

Authors

Yue Wu^{1

2

3}, Baolin Tang^{1

2

3}, Kaidi Song¹, Guangyu Sun^{1

2

3}, Meijuan Tu¹, Xiang Wan^{1

2

3}, Wen Yao¹, Ping Qiang¹, Tianzhong Pan^{1

2

3}, Peng Ding^{1

2

3}, Xiaoyu Zhu^{1

2

3}

Affiliations

¹ Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
² Anhui Provincial Key Laboratory of Blood Research and Applications, Hefei, China.
³ Blood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

PMID: 35715873
DOI: 10.1111/bjh.18316

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cord Blood Stem Cell Transplantation*
Fetal Blood
Graft vs Host Disease*
HLA Antigens
Hematologic Neoplasms* / therapy
Hematopoietic Stem Cell Transplantation*
Histocompatibility Testing
Humans

Substances

HLA Antigens